Janssen Biotech, a Johnson & Johnson company, has entered into a definitive agreement to acquire BeneVir Biopharm, a privately-held company specializing in the development of oncolytic immunotherapies, for as much as $1 billion. The transaction, subject to customary closing conditions, is expected to close in the second quarter of 2018. BeneVir […]
Post Type Archives: News
MHRA issues 5-year post-Brexit plan
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced a five-year corporate plan for 2018 to 2023 that highlights how the agency plans to address earlier outlined challenges from its last corporate plan period as well as what it labels as its most significant challenge, the UK’s exit from the European Union. The […]
Bayer to sell crop science businesses to BASF for up to $2 billion
Bayer has agreed to sell additional crop science businesses to BASF for up to €1.7 billion ($2 billion), following a 2017 sale agreement between the companies. Bayer is in the process of acquiring Monsanto, a St Louis, Missouri-headquartered agrochemical and seed company, for $66 billion, which contains conditions, including the divestment of certain Bayer businesses, […]
BioSafe Systems launches new food safety product SaniDate15.0
BioSafe Systems has launched anew 15% Peroxyacetic Acid (PAA) sanitizer for produce packing and processing waters called SaniDate15.0, following the completion of a Fruit and Vegetable Processing Water Study, which proves SaniDate15.0 to be effective against foodborne pathogens (e.g. E. coli O157:H7, Listeria, Salmonella) at a minimum of 40 parts per million of PAA in the […]
Sumitomo Chemical launches breakthrough fungicide for bananas
The Sumitomo Chemical Company Plantation Solutions team is launching its new Powmyl fungicide (diethofencarb) at the ACORBAT-CORBANA Banana Congress this week. Rapid adoption of Powmyl is expected for Black Sigatoka control programs on banana plantations throughout Latin America. Black Sigatoka is the most important disease in banana crops, where infected plants can suffer dramatic […]
United Therapeutics to acquire SteadyMed in $216 million deal
United Therapeutics, a Silver Spring, Maryland-headquartered biotechnology company developing therapies for treating pulmonary arterial hypertension (PAH), has signed an agreement to acquire SteadyMed, a San Ramon, California-headquartered specialty pharmaceutical company, for a total value of $216 million. Under the agreement, United Therapeutics will acquire SteadyMed for $4.46 per share in cash at closing and an […]
Brenntag presents new sustainability report: CO2 reduction and sustainable procurement
Brenntag, the global market leader in chemical distribution, has published its Sustainability Report for the Financial Year 2017. In this Group report, the company presents its performance in the field of sustainability and documents its global activities and achievements in the areas of safety, environmental protection, supply chain responsibility, employees and social envolvement. Steven Holland, […]
Applied DNA completes leather supply chain tagging project
Applied DNA Sciences has announced the successful completion of its consortium research project with BLC Leather Technology Centre Limited (BLC) based in the UK. The aims of the research project were to apply and recover DNA tags throughout the following key processing stages: Apply DNA to animals on a farm and test for recovery when […]
Thermo Fisher collaborates with Daiichi and Takeda
Thermo Fisher Scientific has signed new agreements with Daiichi Sankyo and Takeda Pharmaceuticals to expand the clinical use of Oncomine Dx Target Test to support clinical trials and drug development programs. The agreements will focus on validating additional biomarkers and gene variants on the test and support Thermo Fisher’s efforts to further enable precision oncology. […]
CordenPharma announces oligonucleotide API manufacturing expansion
CordenPharma is pleased to announce the expansion of new commercial Oligonucleotide API Manufacturing capabilities in its FDA inspected CordenPharma Colorado (Boulder, CO, USA) facility. The expansion, which was completed in Q1 2018, will provide cGMP oligonucleotide manufacturing capacity up to 2mol, with a significant increase in total commercial capacity up to 500kg annually, making CordenPharma […]